Future research should focus on large-scale, high-quality studies to fully elucidate which supplements are most beneficial and how best to incorporate them into comprehensive autism management strategies
Food and Drug Administration has warned that unapproved and compounded versions of GLP-1 drugs carry real safety risks
Proposed hypotheses include increased proliferation of intestinal CCK-secreting cells, heightened parasympathetic nerve activity, and activation of factors that promote CCK release within the intestinal lumen [42, 53, 86, 87]
Maia Anderson Maia Anderson is a senior reporter at Healthcare Brew, where she focuses on pharma developments like GLP-1s and psychedelic medicine, pharmacies, and women's health.
It sold out within hours at LifeVantages Market Connect event and quickly depleted e-commerce inventory within days